Parkinson semptomlarına karşı ketamin. Ketarx faz 3
thepsychedelicpulse.com/2023/08/04/ket…

$PHRRF .2239 tagged next leg up we get a .2810 print.
Congrats Longs
@NYDOUGH_PRO lead this trade from .11 added .1368 hold some decent size Nice TRIP so far +71% at this point Here was our outline from 12/7 and a fresh #MAP today #Ketarx #Ketamine Elon Musk #Elon What Say You?

🚨 INVE$TORS 👋 #KETARX / #Ketamine

🇨🇦 PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE:PHRM) 🎯
Expected Milestones for 2024 as per Corporate Presentation: pharmather.com/uploads/1/2/5/…

$PHRM $PHRRF $PHRM.C #Anesthesiology #Anesthesia #TSX v #TSX #OTCMarkets #OTCQB #ClinicalTrials #BioTech #MedTwitter #FDA #HealthCanada

PHRRF: Ketarx Projected Sales: The Company forecasts that it could sell up to one million units at an average wholesale price between USD $25 and USD $40 per unit, resulting in potential total gross sales of USD $25-40 million.

PHRRF: KETARX:The Company’s lead product is KETARX™ (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. FDA Approval: April 2024

วันนี้จะมาสวมบทบาทเป็นหนูน้อยหมวกแดงไปหาคุณยายกันค่ะ !

Rex Wiggins Maybe the pain is almost over ....
If its not we can always sell for these gems & ride it out 😆

#ChampionsLeague #Bullrun #Bullrun 2024 #KETARX #BTC #Web3 #WednesdayMotivation #Wednesdayvibe #warrants

Breaking news as Pharmather and Vitruvias join forces to commercialize KETARX ketamine drug in the US. PharmaTher also announces FDA approval timeline. Read more on our blog $PHRM.CN

#mentalhealth #microdosing #ketamine microdose.buzz/news/pharmathe…

Trending on Bolt:

CENTR Enters Esports With An OpTic Gaming™ Gaming Media Partnership

Hypercharge Selected to Bring EV Charging in Prince Edward Island

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE:PHRM) Announces FDA Grant of Orphan Drug Designation to KETARX

$CBIT $MOGO $PTK $CNTR $HC $PHRM $TSX $CSE

$PHRRF entered into a collaboration agreement with Vitruvias Therapeutics, Inc. to commercialize the Company’s KETARX (racemic ketamine) products in the U.S.

$PIRS $QURE $OCEA $EVGN $BCDA $VRDN $ALDX $ALVR

Read more:
biopharmcatalyst.com/news/2023/alde…

Another new 52 week high. Momentum building up ahead of the FDA approval of Ketarx (regilated source of Ketamine) zerohedge Barchart The Market Ear

PHRRF: $.22
09/23
The FDA has given its stamp of approval to their groundbreaking new drug application for KETARX, a racemic ketamine product. The goal date for the priority original Abbreviated New Drug Application (ANDA) has been set for April 29, 2024.beststocks.com/fda-approves-p…

Interesting article by investinthethirdwave.com. At a CAGR of over 15%, ketamine treatment market is estimated to be $26B in 2030. $PHRRF recently released that the FDA approval date of April 29, 2024, for its KETARX is on track Rex Wiggins Microdose Psychedelic Insights NuNrg PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE:PHRM)

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets - PharmaTher Holdings ( OTC:PHRRF ) , Field Trip Health ( OTC:FTHWF )
benzinga.com/markets/cannab…

New 52 week high and great new presentation with FDA approval timeline for their product Ketarx (regulated source of ketamine) from our holding $PHRM $PHRRF. Momentum building up towards that FDA goal date of April 29, 2024. Congrats to the team Fabio Chianelli #ketamine

News: PharmaTher Holdings | $PHRM $PHRRF

Announced that the FDA has granted orphan drug designation to KETARX, $PHRM's racemic ketamine for the treatment of Rett Syndrome, a rare genetic neurological disorder.

psychedelicfinance.com/articles/pharm…

$PHRRF BUY ALERT!! 🔥🔥
The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural Rex Wiggins
marketbeat.com/stocks/OTC/PHR…

Ketamine Ketarx - PharmaTher Holdings Ltd. Ketamine pharmather.com/ketamine.html?…

FDA Grants Pharmather Orphan Drug Designation for KETARX (Ketamine)

The article FDA Grants Pharmather Orphan Drug Designation for KETARX (Ketamine) was originally published on Microdose.

#psychedelics #StocksToBuy #trading

bit.ly/3wNo7b8

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets – PharmaTher Holdings (OTC: $PHRRF), Field Trip Health (OTC: $FTHWF) old.billionaireclubcollc.com/ketamine-news-…